Biomarker Services
High-performance (multi-array) ligand-binding assays
In vitro and in vivo studies: one sample – multiple readouts
The GBA Group supports the entire process of preclinical drug development: pharmacokinetics, pharmacodynamics, and toxicology, in order to predict the risk of harmful reactions and help you to choose the most suitable candidate for clinical trials.
Using leading-edge multi-array technologies we offer multiplex high-throughput detection, quantification and characterization of Biomarkers (cytokines, hormones, enzymes) and Biopharmaceuticals (e.g. monoclonal antibodies) in different biological matrices from pre-clinical (non-GLP/GLP) as well as clinical studies (GCLP).
These technologies require only small sample volumes and allow multiplex tests on a single sample with high sensitivity and reliability.
Ihr direkter Kontakt
Dr. Daniel Da Costa
BD Director Preclinical Services Europe
Pharmacokinetic / Toxicokinetic
- Safety and Efficacy Determination
- Liver and Kidney-tox
Biomarker Analysis
- Metabolic
- Immune
- Cancer
- Neuroscience
- Allergic reaction
Immunogenicity Testing
- Screening Assay
Immuneresponse
- Innate
- Adaptive
- Anti-drug Antibodies
Matrixes
- Ability to analyze a wide range of sample types e.g. cell culture supernatant, cell lysates/tissue homogenates, serum/plasma, whole Blood, sputum, urine, CSF, tumor extracts, tears, etc.
Technology
- Luminex - xMAP (multianalyte profiling) Technology
- Mesoscale MSD - Electrochemiluminescence based Multi-Array Technology
